FAQs about our Team

From 2008.igem.org

(Difference between revisions)
Line 21: Line 21:
   <o:Revision>2</o:Revision>
   <o:Revision>2</o:Revision>
   <o:TotalTime>0</o:TotalTime>
   <o:TotalTime>0</o:TotalTime>
-
   <o:Created>2008-10-23T00:12:00Z</o:Created>
+
   <o:Created>2008-10-23T00:24:00Z</o:Created>
-
   <o:LastSaved>2008-10-23T00:12:00Z</o:LastSaved>
+
   <o:LastSaved>2008-10-23T00:24:00Z</o:LastSaved>
   <o:Pages>1</o:Pages>
   <o:Pages>1</o:Pages>
   <o:Words>315</o:Words>
   <o:Words>315</o:Words>
-
   <o:Characters>1801</o:Characters>
+
   <o:Characters>1797</o:Characters>
   <o:Company>UCSF</o:Company>
   <o:Company>UCSF</o:Company>
-
   <o:Lines>15</o:Lines>
+
   <o:Lines>14</o:Lines>
   <o:Paragraphs>3</o:Paragraphs>
   <o:Paragraphs>3</o:Paragraphs>
-
   <o:CharactersWithSpaces>2211</o:CharactersWithSpaces>
+
   <o:CharactersWithSpaces>2206</o:CharactersWithSpaces>
   <o:Version>11.1280</o:Version>
   <o:Version>11.1280</o:Version>
  </o:DocumentProperties>
  </o:DocumentProperties>
Line 77: Line 77:
text-indent:-.25in;
text-indent:-.25in;
mso-pagination:widow-orphan;
mso-pagination:widow-orphan;
-
mso-list:l0 level1 lfo10;
+
mso-list:l0 level1 lfo3;
tab-stops:list .5in;
tab-stops:list .5in;
font-size:12.0pt;
font-size:12.0pt;
Line 173: Line 173:
<p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><span
<p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><span
-
style='font-family:Arial'><b>Q. <span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>How
+
style='font-size:11.0pt;font-family:Arial'><b>Q. How is control of gene
-
is control of gene expression by chromatin different from control by transcription
+
expression by chromatin different from control by transcription factors (and
-
factors (and what are its advantages)?<o:p></o:p></b></span></p>
+
what are its advantages)?<o:p></o:p></b></span></p>
-
<p class=MsoNormal><span style='font-family:Arial'><b>A. <span
+
<p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><span
-
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Chromatin
+
style='font-size:11.0pt;font-family:Arial'><b><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></b></span></p>
-
is a completely different level of gene expression control.<o:p></o:p></b></span></p>
+
-
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
+
<p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><b>A.
-
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
+
Chromatin is a completely different level of gene expression control.<o:p></o:p></b></span></p>
-
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
-
</span></span><![endif]>Dominant over transcription factors (resistant to
+
-
noise).</p>
+
-
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5;
-
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt;
-
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
</span></span><![endif]>Regional &#8211; silences domains, not individual genes
+
</span></span><![endif]><span style='font-size:11.0pt'>Dominant over
-
(reduces the engineering required for regulation of complex multi-gene
+
transcription factors (resistant to noise).<o:p></o:p></span></p>
-
systems).</p>
+
-
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5;
-
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt;
-
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
</span></span><![endif]>Memory&#8211;Alteration in gene expression lasts for
+
</span></span><![endif]><span style='font-size:11.0pt'>Regional &#8211;
-
multiple generations (epigenetic control).</p>
+
silences domains, not individual genes (reduces the engineering required for
 +
regulation of complex multi-gene systems).<o:p></o:p></span></p>
-
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5;
-
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt;
-
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
</span></span><![endif]>Intrinsically bistable, i.e. all-or-none expression
+
</span></span><![endif]><span style='font-size:11.0pt'>Memory&#8211;Alteration
-
(increases parameter space over which circuits are predicted to be stable).</p>
+
in gene expression lasts for multiple generations (epigenetic control).<o:p></o:p></span></p>
-
<p class=MsoNormal><span style='font-family:Arial'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5;
 +
tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt;
 +
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
 +
</span></span><![endif]><span style='font-size:11.0pt'>Intrinsically bistable,
 +
i.e. all-or-none expression (increases parameter space over which circuits are
 +
predicted to be stable).<o:p></o:p></span></p>
-
<p class=MsoNormal><span style='font-family:Arial'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>
+
<p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>
 +
 
 +
<p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>
<p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><span
<p class=MsoNormal style='margin-left:.5in;text-indent:-.5in'><span
-
style='font-family:Arial'><b>Q. <span style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>What
+
style='font-size:11.0pt;font-family:Arial'><b>Q. What applications could this
-
applications could this type of synthetic chromatin control system be used for?<o:p></o:p></b></span></p>
+
type of synthetic chromatin control system be used for?<o:p></o:p></b></span></p>
-
<p class=MsoNormal><span style='font-family:Arial'><b>A. <span
+
<p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><b><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></b></span></p>
-
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>To
+
-
stably and permanently switch cells between different states characterized by significant differences in gene expression (i.e. cellular differentiation).<o:p></o:p></b></span></p>
+
-
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l2 level2 lfo5;
+
<p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><b>A. To
-
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
+
stably and permanently switch cells between different states characterized by
-
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
significant differences in gene expression (i.e. cellular differentiation).<o:p></o:p></b></span></p>
-
</span></span><![endif]>In bio-production&#8211;for coordinated switching
+
-
between a growth phase and a production phase.</p>
+
-
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l3 level1 lfo7;
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l2 level2 lfo7;
-
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt;
-
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
</span></span><![endif]>In bio-production&#8211;to differentiate a clonal
+
</span></span><![endif]><span style='font-size:11.0pt'>In
-
population of cells into a distribution of subtypes that function cooperatively
+
bio-production&#8211;for coordinated switching between a growth phase and a
-
(“factory” with different specialized “workers”).</p>
+
production phase.<o:p></o:p></span></p>
-
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l3 level1 lfo9;
-
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt;
-
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
</span></span><![endif]>To reprogram cell fate in a highly specific manner
+
</span></span><![endif]><span style='font-size:11.0pt'>In
-
(e.g. stem cell engineering, correction of epigenetic abnormalities in cancer
+
bio-production&#8211;to differentiate a clonal population of cells into a
-
cells).</p>
+
distribution of subtypes that function cooperatively (“factory” with different
 +
specialized “workers”).<o:p></o:p></span></p>
-
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5;
-
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt;
-
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
</span></span><![endif]>To create cells with highly digital computational
+
</span></span><![endif]><span style='font-size:11.0pt'>To reprogram cell fate
-
capabilities.</p>
+
in a highly specific manner (e.g. stem cell engineering, correction of
 +
epigenetic abnormalities in cancer cells).<o:p></o:p></span></p>
-
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5;
-
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt;
-
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
</span></span><![endif]>To study chromatin spreading mechanism in a
+
</span></span><![endif]><span style='font-size:11.0pt'>To create cells with
-
quantitative and controlled way.</p>
+
highly digital computational capabilities.<o:p></o:p></span></p>
-
<p class=MsoNormal style='margin-left:.25in'><span style='font-family:Arial'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5;
 +
tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt;
 +
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
 +
</span></span><![endif]><span style='font-size:11.0pt'>To study chromatin
 +
spreading mechanism in a quantitative and controlled way.<o:p></o:p></span></p>
-
<p class=MsoNormal style='margin-left:.25in'><span style='font-family:Arial'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>
+
<p class=MsoNormal style='margin-left:.25in'><span style='font-size:11.0pt;
 +
font-family:Arial'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>
-
<p class=MsoNormal><span style='font-family:Arial'><b>Q. <span
+
<p class=MsoNormal style='margin-left:.25in'><span style='font-size:11.0pt;
-
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Could
+
font-family:Arial'><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></span></p>
 +
 
 +
<p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><b>Q. Could
this type of yeast synthetic chromatin control system be utilized in other cell
this type of yeast synthetic chromatin control system be utilized in other cell
types, including mammalian cells?<o:p></o:p></b></span></p>
types, including mammalian cells?<o:p></o:p></b></span></p>
-
<p class=MsoNormal><span style='font-family:Arial'><b>A. <span
+
<p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><b><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></b></span></p>
-
style='mso-tab-count:1'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span>Yes,
+
 
 +
<p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><b>A. Yes,
the approach should be transferable.<o:p></o:p></b></span></p>
the approach should be transferable.<o:p></o:p></b></span></p>
-
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5;
-
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt;
-
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
</span></span><![endif]>Core elements of this system are: initiator, covalent
+
</span></span><![endif]><span style='font-size:11.0pt'>Core elements of this
-
mark, spreading (polymerization).</p>
+
system are: initiator, covalent mark, spreading (polymerization).<o:p></o:p></span></p>
-
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5;
-
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt;
-
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
</span></span><![endif]>In <i>S. cerevisiae</i><span style='font-style:normal'>,
+
</span></span><![endif]><span style='font-size:11.0pt'>In <i>S. cerevisiae</i></span><span
-
covalent mark is deacetylation&#8211;we use an initiator (LexA-Sir2) that when
+
style='font-size:11.0pt'>, covalent mark is deacetylation&#8211;we use an
-
localized deacetylates adjacent histones.<span style="mso-spacerun: yes">&nbsp;
+
initiator (LexA-Sir2) that when localized deacetylates adjacent histones.<span
-
</span>This leads to further recruitment of Sir2, which propagates the mark
+
style="mso-spacerun: yes">&nbsp; </span>This leads to further recruitment of
-
outward. Deacetylated chromatin adopts a “closed” conformation. </span></p>
+
Sir2, which propagates the mark outward. Deacetylated chromatin adopts a
 +
“closed” conformation. <o:p></o:p></span></p>
-
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo3;
+
<p class=MsoListBullet2 style='margin-left:1.0in;mso-list:l1 level2 lfo5;
-
tab-stops:list 1.0in'><![if !supportLists]><span style='font-family:Symbol'>·<span
+
tab-stops:list 1.0in'><![if !supportLists]><span style='font-size:11.0pt;
-
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
+
font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
-
</span></span><![endif]>For higher eukaryotes, from <i>S. pombe</i><span
+
</span></span><![endif]><span style='font-size:11.0pt'>For higher eukaryotes,
-
style='font-style:normal'> to human, the covalent mark is methylation,
+
from <i>S. pombe</i></span><span style='font-size:11.0pt'> to human, the
-
initiator is a histone methyltransferase. But in principle, a similar system
+
covalent mark is methylation, initiator is a histone methyltransferase. But in
-
should work.<span style="mso-spacerun: yes">&nbsp; </span>Same logical design,
+
principle, a similar system should work.<span style="mso-spacerun: yes">&nbsp;
-
with different catalytic functions propagating spread.</span></p>
+
</span>Same logical design, with different catalytic functions propagating
 +
spread.<o:p></o:p></span></p>
-
<p class=MsoNormal><span style='font-family:Arial'><span style="mso-spacerun:
+
<p class=MsoNormal><span style='font-size:11.0pt;font-family:Arial'><span
-
yes">&nbsp;</span><o:p></o:p></span></p>
+
style="mso-spacerun: yes">&nbsp;</span><o:p></o:p></span></p>
</div>
</div>
Line 295: Line 306:
</html>
</html>
-
 
-
 
-
 

Revision as of 00:24, 23 October 2008

Frequently asked questions (FAQs) on Synthetic Chromatin

Q. How is control of gene expression by chromatin different from control by transcription factors (and what are its advantages)?

 

A. Chromatin is a completely different level of gene expression control.

·        Dominant over transcription factors (resistant to noise).

·        Regional – silences domains, not individual genes (reduces the engineering required for regulation of complex multi-gene systems).

·        Memory–Alteration in gene expression lasts for multiple generations (epigenetic control).

·        Intrinsically bistable, i.e. all-or-none expression (increases parameter space over which circuits are predicted to be stable).

 

 

Q. What applications could this type of synthetic chromatin control system be used for?

 

A. To stably and permanently switch cells between different states characterized by significant differences in gene expression (i.e. cellular differentiation).

·        In bio-production–for coordinated switching between a growth phase and a production phase.

·        In bio-production–to differentiate a clonal population of cells into a distribution of subtypes that function cooperatively (“factory” with different specialized “workers”).

·        To reprogram cell fate in a highly specific manner (e.g. stem cell engineering, correction of epigenetic abnormalities in cancer cells).

·        To create cells with highly digital computational capabilities.

·        To study chromatin spreading mechanism in a quantitative and controlled way.

 

 

Q. Could this type of yeast synthetic chromatin control system be utilized in other cell types, including mammalian cells?

 

A. Yes, the approach should be transferable.

·        Core elements of this system are: initiator, covalent mark, spreading (polymerization).

·        In S. cerevisiae, covalent mark is deacetylation–we use an initiator (LexA-Sir2) that when localized deacetylates adjacent histones.  This leads to further recruitment of Sir2, which propagates the mark outward. Deacetylated chromatin adopts a “closed” conformation.

·        For higher eukaryotes, from S. pombe to human, the covalent mark is methylation, initiator is a histone methyltransferase. But in principle, a similar system should work.  Same logical design, with different catalytic functions propagating spread.

 


Home The Team The Project Parts Submitted to the Registry Modeling Human Practices Notebooks